Germany
· Delayed Price · Currency is EUR Redcare Pharmacy NV Statistics
Total Valuation
FRA:RDC has a market cap or net worth of EUR 2.06 billion. The enterprise value is 2.14 billion.
| Market Cap | 2.06B |
| Enterprise Value | 2.14B |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 20.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 30.91 |
| P/FCF Ratio | 106.51 |
| P/OCF Ratio | 54.08 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -44.22 |
| EV / Sales | 0.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 110.73 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.80 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | 12.75 |
| Interest Coverage | -4.53 |
Financial Efficiency
Return on equity (ROE) is -9.60% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -9.60% |
| Return on Assets (ROA) | -2.33% |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | -5.16% |
| Revenue Per Employee | 1.38M |
| Profits Per Employee | -26,533 |
| Employee Count | 1,827 |
| Asset Turnover | 2.48 |
| Inventory Turnover | 13.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.92% |
| 50-Day Moving Average | 122.57 |
| 200-Day Moving Average | 129.84 |
| Relative Strength Index (RSI) | 24.58 |
| Average Volume (20 Days) | 147,030 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:RDC had revenue of EUR 2.53 billion and -48.48 million in losses.
| Revenue | 2.53B |
| Gross Profit | 582.19M |
| Operating Income | -37.98M |
| Pretax Income | -51.71M |
| Net Income | -48.48M |
| EBITDA | -15.35M |
| EBIT | -37.98M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 184.82 million in cash and 246.82 million in debt, giving a net cash position of -62.00 million.
| Cash & Cash Equivalents | 184.82M |
| Total Debt | 246.82M |
| Net Cash | -62.00M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 493.67M |
| Book Value Per Share | n/a |
| Working Capital | 228.48M |
Cash Flow
In the last 12 months, operating cash flow was 38.13 million and capital expenditures -18.77 million, giving a free cash flow of 19.36 million.
| Operating Cash Flow | 38.13M |
| Capital Expenditures | -18.77M |
| Free Cash Flow | 19.36M |
| FCF Per Share | n/a |
Margins
Gross margin is 23.03%, with operating and profit margins of -1.50% and -1.92%.
| Gross Margin | 23.03% |
| Operating Margin | -1.50% |
| Pretax Margin | -2.05% |
| Profit Margin | -1.92% |
| EBITDA Margin | -0.61% |
| EBIT Margin | -1.50% |
| FCF Margin | 0.77% |
Dividends & Yields
FRA:RDC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.35% |
| FCF Yield | 0.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |